{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:29:43Z","timestamp":1790627383016,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"am","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ancard.2020.03.018","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T17:29:49Z","timestamp":1587144589000},"page":"139-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact du d\u00e9remboursement de l\u2019olm\u00e9sartan chez les patients hypertendus en soins premiers"],"prefix":"10.1016","volume":"69","author":[{"given":"X.","family":"Humbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rabiaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Schonbrodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Raginel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Le Bas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"33","key":"10.1016\/j.ancard.2020.03.018_bib0080","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018\u00a0ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2020.03.018_bib0085","series-title":"Panorama mondial de l\u2019hypertension","author":"O.M.S.","year":"2013"},{"key":"10.1016\/j.ancard.2020.03.018_bib0090","series-title":"Prise en charge de l\u2019hypertension art\u00e9rielle de l\u2019adulte","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2016"},{"key":"10.1016\/j.ancard.2020.03.018_bib0095","series-title":"Base de donn\u00e9es publique des m\u00e9dicaments. Fiche info - ALTEIS 10mg, comprim\u00e9 pellicul\u00e9","year":"2018"},{"issue":"8","key":"10.1016\/j.ancard.2020.03.018_bib0100","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.mayocp.2012.06.003","article-title":"Severe spruelike enteropathy associated with olmesartan","volume":"87","author":"Rubio-Tapia","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ancard.2020.03.018_bib0105","series-title":"Drug Safety Communication_olmesartan","first-page":"4","author":"Food and Drug Administration","year":"2013"},{"key":"10.1016\/j.ancard.2020.03.018_bib0110","unstructured":"ANSM - Cas graves d\u2019ent\u00e9ropathies associ\u00e9s avec l\u2019olm\u00e9sartan m\u00e9doxomil - Point d\u2019information - ANSM\u00a0: Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 2018. Disponible sur\u00a0: https:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Cas-graves-d-enteropathies-associes-avec-l-olmesartan-medoxomil-Point-d-information."},{"key":"10.1016\/j.ancard.2020.03.018_bib0115","series-title":"Exposition aux diff\u00e9rents sartans et risque d\u2019ent\u00e9ropathies","first-page":"6","author":"Mezzarobba","year":"2014"},{"key":"10.1016\/j.ancard.2020.03.018_bib0120","series-title":"Commission de transparence- olm\u00e9sartan","author":"H.A.S.","year":"2015"},{"key":"10.1016\/j.ancard.2020.03.018_bib0125","series-title":"Confirmation arr\u00eat olmesartan","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2015"},{"issue":"3","key":"10.1016\/j.ancard.2020.03.018_bib0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ancard.2018.04.024","article-title":"The repercussion of stopping reimbursement of olmesartan on antihypertensive drugs prescription and blood pressure control of treated hypertensive patients in France","volume":"67","author":"Dufay","year":"2018","journal-title":"Ann Cardiol Angeiol"},{"issue":"4","key":"10.1016\/j.ancard.2020.03.018_bib0135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0000000000000881","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.ancard.2020.03.018_bib0140","series-title":"R\u00e9mun\u00e9ration sur objectifs de sant\u00e9 publique\u00a0: bilan et pistes d\u2019\u00e9volution","author":"Caisse nationale d\u2019Assurance maladie","year":"2016"},{"issue":"12","key":"10.1016\/j.ancard.2020.03.018_bib0145","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1007\/s00125-011-2325-z","article-title":"Effects of olmesartan on renal and cardiovascular outcomes in type 2\u00a0diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study","volume":"54","author":"Imai","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.ancard.2020.03.018_bib0075","first-page":"170","article-title":"L\u2019hypertension art\u00e9rielle en France\u00a0: pr\u00e9valence, traitement et contr\u00f4le en 2015\u00a0et \u00e9volutions depuis 2006","volume":"10","author":"Perrine","year":"2018","journal-title":"Bull Epid\u00e9miol Hebd"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392820300536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392820300536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:37:15Z","timestamp":1757716635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392820300536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0003392820300536"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2020.03.018","relation":{},"ISSN":["0003-3928"],"issn-type":[{"value":"0003-3928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact du d\u00e9remboursement de l\u2019olm\u00e9sartan chez les patients hypertendus en soins premiers","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2020.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}